Skip to main content
Premium Trial:

Request an Annual Quote

EU Approves Celera's HCV Genotyping Test

NEW YORK (GenomeWeb News) – The Europen Union awarded the CE Mark to Celera Genomics' hepatitis C virus genotyping test, parent Applera said today.
 
Celera developed the RealTime HCV Genotype Assay with Abbott. It will be sold as part of this alliance. The test is designed to be used on Applied Biosystems' PRISM 7000 PCR system.
 
Called the Abbott RealTime HCV Genotype test, it complements the HCV quantitative viral load test available on Abbott’s m2000 system.
 
The regulatory approval allows the genotype assay to be sold in the European Union as a diagnostic product. This is the first real-time test for genotyping the HCV virus to obtain regulatory approval for commercial sale in Europe, Applera said.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.